Literature DB >> 27112289

Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs.

Sara B E Andersson1, Caroline Alvebratt1, Jan Bevernage2, Damien Bonneau3, Claudia da Costa Mathews4, Rikesh Dattani5, Khadijah Edueng1, Yan He6, René Holm7, Cecilie Madsen8, Thomas Müller9, Uwe Muenster10, Anette Müllertz8, Krista Ojala11, Thomas Rades8, Peter Sieger12, Christel A S Bergström13.   

Abstract

The purpose of this study was to investigate the interlaboratory variability in determination of apparent solubility (Sapp) and intrinsic dissolution rate (IDR) using a miniaturized dissolution instrument. Three poorly water-soluble compounds were selected as reference compounds and measured at multiple laboratories using the same experimental protocol. Dissolution was studied in fasted-state simulated intestinal fluid and phosphate buffer (pH 6.5). An additional 6 compounds were used for the development of an IDR measurement guide, which was then validated with 5 compounds. The results clearly showed a need for a standardized protocol including both the experimental assay and the data analysis. Standardization at both these levels decreased the interlaboratory variability. The results also illustrated the difficulties in performing disc IDR on poorly water-soluble drugs because the concentrations reached are typically below the limit of detection. The following guidelines were established: for compounds with Sapp >1 mg/mL, the disc method is recommended. For compounds with Sapp <100 μg/mL, IDR is recommended to be performed using powder dissolution. Compounds in the interval 100 μg/mL to 1 mg/mL can be analyzed with either of these methods.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  apparent solubility; dissolution; intrinsic dissolution rate; poorly water-soluble drug; preformulation; small scale

Mesh:

Substances:

Year:  2016        PMID: 27112289     DOI: 10.1016/j.xphs.2016.03.010

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms.

Authors:  Shaquib Rahman Ansari; Nele-Johanna Hempel; Shno Asad; Peter Svedlindh; Christel A S Bergström; Korbinian Löbmann; Alexandra Teleki
Journal:  ACS Appl Mater Interfaces       Date:  2022-04-22       Impact factor: 10.383

2.  Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds.

Authors:  Sara B E Andersson; Caroline Alvebratt; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-06-15       Impact factor: 4.200

3.  Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.

Authors:  Khadijah Edueng; Denny Mahlin; Per Larsson; Christel A S Bergström
Journal:  J Control Release       Date:  2017-04-12       Impact factor: 9.776

4.  Characterizing the Physicochemical Properties of Two Weakly Basic Drugs and the Precipitates Obtained from Biorelevant Media.

Authors:  Miao Zhang; Bin Wu; Shudong Zhang; Lin Wang; Qin Hu; Dongyang Liu; Xijing Chen
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

5.  Prediction of aqueous intrinsic solubility of druglike molecules using Random Forest regression trained with Wiki-pS0 database.

Authors:  Alex Avdeef
Journal:  ADMET DMPK       Date:  2020-03-04

6.  Determination of Intrinsic Drug Dissolution and Solute Effective Transport Rate during Laminar Fluid Flow at Different Velocities.

Authors:  Sara B E Andersson; Göran Frenning; Göran Alderborn
Journal:  Pharmaceutics       Date:  2021-06-04       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.